Random-start GnRH antagonist for emergency fertility preservation: a self-controlled trial
| Autor: | Juan José Espinós, Margalida E Sastre, Laura Marque, Julio Herrero, Miguel A. Checa, Mario Brassesco, Arturo Brassesco, Manuel Gómez |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
medicine.medical_specialty
Emergency fertility preservation media_common.quotation_subject Controlled ovarian hyperstimulation International Journal of Women's Health Luteal phase Ovaris -- Malalties controlled ovarian hyperstimulation law.invention Randomized controlled trial law Maternity and Midwifery Follicular phase medicine Fertility preservation Ganirelix Menstrual cycle media_common Original Research Gynecology business.industry Obstetrics and Gynecology Cancer patients Càncer -- Pacients Clinical trial Oncology emergency fertility preservation GnRH antagonists business cancer patients medicine.drug |
| Zdroj: | International Journal of Women's Health Dipòsit Digital de Documents de la UAB Universitat Autònoma de Barcelona |
| ISSN: | 1179-1411 |
| Popis: | Miguel A Checa,1,2 Mario Brassesco,2 Margalida Sastre,1 Manuel Gómez,2 Julio Herrero,3 Laura Marque,3 Arturo Brassesco,2 Juan José Espinós3 1Department of Obstetrics and Gynecology, Parc de Salut Mar, Universitat Autònoma de Barcelona, 2Centro de Infertilidad y Reproducción Humana (CIRH), 3Centro de Reproducción Asistida Sagrada Familia, Clínica Sagrada Familia, Barcelona, Spain Abstract: The aim of this study is to evaluate the feasibility and safety of random-start controlled ovarian hyperstimulation (COH) for emergency fertility preservation, regardless of the phase of the menstrual cycle. A self-controlled pilot clinical trial (NCT01385332) was performed in an acute-care teaching hospital and in two private reproductive centers in Barcelona, Spain. Eleven egg donors participated in the study. Two random-start gonadotropin-releasing hormone (GnRH) antagonist protocols were assessed in which ganirelix was initiated on either day 10 (protocol B) or on day 20 (protocol C) of the menstrual cycle and was continued until estradiol levels were below 60 pg/dL. These protocols were compared with a standard protocol (protocol A). The main outcome of interest was the number of metaphase 2 oocytes retrieved. Results from this study show that the number of mature oocytes retrieved was comparable across the different protocols (14.3±4.6 in the standard protocol versus 13.0±9.1 and 13.2±5.2 in protocols B and C, respectively; values expressed as mean ± standard deviation). The mean number of days needed for a GnRH antagonist to lower estradiol levels, as well as the ongoing pregnancy rates, were also similar when protocols B (stimulation in follicular phase) and C (stimulation on luteal phase) were compared with protocol A (standard stimulation). GnRH antagonists can be effectively used for random-start controlled ovarian hyperstimulation with an ovarian response similar to that of standard protocols, and the antagonists appear suitable for emergency fertility preservation in cancer patients. Keywords: controlled ovarian hyperstimulation, GnRH antagonists, emergency fertility preservation, cancer patients |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|